Healthcare Marketing Compliance Best Practices After Launch

What to take away

Healthcare marketing compliance best practices turn review from a late copy edit into an operating discipline. The program should influence product choices, data design, vendor access, campaign assembly, delivery, measurement, and correction.

Ask whether the program works

The Justice Department's Evaluation of Corporate Compliance Programs, revised in March 2023, is structured around program design, resourcing and empowerment, and performance in practice. It is prosecutorial guidance, not a private certification or a complete healthcare rule map. Use its questions to challenge assumptions and preserve evidence of the organization's answers.

Keep the program active

An HHS OIG transcript on compliance program basics says written policies are only a starting point. It covers monitoring, enforcement, reporting, and prompt response. This is older general guidance.

Use it with HHS OIG's General Compliance Program Guidance, issued in November 2023. The guidance describes seven elements: written policies and procedures; compliance leadership and oversight; training and education; effective lines of communication; enforcing standards; risk assessment, auditing, and monitoring; and responding to detected offenses with corrective action. These are program elements, not a substitute for the rules governing a campaign. The same logic applies to healthcare marketing compliance benchmarks, which test whether written policies change behavior.

Build a campaign-specific legal map rather than treating general guidance as clearance. For patient data, apply the HIPAA Privacy and Security Rules and check whether a marketing use or disclosure requires authorization under 45 CFR 164.508; HHS's Office for Civil Rights (OCR) administers HIPAA. When campaigns involve remuneration or referral arrangements, assess the federal Anti-Kickback Statute and physician self-referral law (Stark Law); for claims to federal health care programs, assess the False Claims Act.

Substantiate health claims under Section 5 of the FTC Act and the FTC's Health Products Compliance Guidance. For FDA-regulated products, review applicable FDA advertising and promotion rules, including restrictions on promoting unapproved uses. For outreach, check TCPA requirements for calls and texts, the CAN-SPAM Act for commercial email, and CMS's Medicare Communications and Marketing Guidelines when marketing Medicare Advantage or Part D plans.

Align incentives with truthful work

Do not reward volume, speed, rating, leads, or spend without evidence and risk guardrails. Give teams credit for raising credible concerns early, correcting mistakes, and retiring unsupported work. Leaders should receive unresolved findings and recurrence, not only completion percentages.

Document decisions with a worked example

A record should explain the facts reviewed, the question, the responsible authority, source version, decision, limitations, dissent, conditions, owner, and next review trigger. It should let a later reviewer understand why a campaign was released, paused, changed, or corrected without reconstructing the decision from email.

Record rejected options and the chosen path because the original constraint may later change. Set the next review date and name the change that would trigger an earlier check.

Worked example: Campaign CP-14, approved 12 March. The claim "clinically proven" rested on a 2019 study of 40 patients. The owner limited the claim to that group and set an expiry of 30 June. The record notes the analytics lead's dissent on sample size and the condition that derived copy may not reuse the claim.

Assign owners and test each practice

The NIST Privacy Framework starting guide outlines a voluntary process for identifying and managing privacy risk. Use it to assign data and response owners; it is not legal clearance. Use common healthcare marketing compliance questions to document who approves data use, grants vendor access, and responds to an incident.

The CISA business-system logging guidance explains how event records support security review. Preserve access, change, failure, and correction records without claiming that logging validates a metric.

Turn each practice into a named owner, cadence, evidence, acceptance test, and correction path. For each campaign, identify the marketing owner, compliance reviewer, privacy or security contact, and person authorized to pause or withdraw the work; assign a reviewer independent of the campaign build to test the evidence. Keep approved copy and claim support, required consent or authorization records, audience and suppression settings, vendor access, delivery logs, and correction records together.

Use risk-based sampling across live campaigns and ordinary reporting cycles: compare sampled delivered assets with the approved version and claim evidence, verify required authorizations or consent and suppression controls, and trace exceptions through escalation and correction. Also observe a controlled failure, such as a source-data defect or access change, to confirm the records show who detected it, who acted, and whether a retest passed.

Common questions

What is the most important best practice?

Make the program powerful enough to change live work and transparent enough to show why decisions were made.

Should compliance report to marketing?

The structure must preserve sufficient independence, access, resources, and escalation for the organization's risk.

How can leaders test culture?

Compare stated values with incentives, raised concerns, treatment of reporters, decision overrides, repeat failures, and actual remediation.